27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
A public commission in Denmark has recommended the cessation of subsidies for GLP-1 drugs, including Ozempic and similar medications, as a primary treatment for type 2 diabetes.
Novo Nordisk A/S (NYSE:NVO) has seen a surge in demand for Ozempic and its sister drug Wegovy, a weight-loss medication based on similar ingredients.
The proposal, which aims to prioritize cost-effective alternatives as the initial therapeutic option, was released on Tuesday and is open for public review and commentary until October 8.
The final decision will rest with the Danish Medicines Agency, Reuters noted.
GLP-1 drugs, hailed for their effectiveness in controlling blood sugar levels, have long been a go-to choice for managing type 2 diabetes.
However, the Danish commission's stance challenges this convention, citing the higher cost of GLP-1 drugs compared to other available treatments. The commission argues that despite their elevated price point, these drugs do not provide a universally superior advantage in treating patients with type 2 diabetes.
According to data from the Danish Medicines Agency, approximately 87,400 individuals in Denmark received subsidized GLP-1 drugs for type 2 diabetes in the previous year.
The European Medicines Agency is investigating Novo Nordisk's weight-loss medications amid reports of suicidal risks associated with these drugs.
The investigation follows referrals from the Icelandic Medicines Agency, which reported two cases of suicidal thoughts linked to the drugs Saxenda and Ozempic.
Price Action: NVO shares are up 0.95% at $186.76 during the premarket session on the last check Wednesday.
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!